GB202302686D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB202302686D0 GB202302686D0 GBGB2302686.7A GB202302686A GB202302686D0 GB 202302686 D0 GB202302686 D0 GB 202302686D0 GB 202302686 A GB202302686 A GB 202302686A GB 202302686 D0 GB202302686 D0 GB 202302686D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2302686.7A GB202302686D0 (en) | 2023-02-24 | 2023-02-24 | Novel compounds |
| EP24710166.0A EP4669662A1 (en) | 2023-02-24 | 2024-02-23 | CONNECTIONS |
| TW113106610A TW202436329A (en) | 2023-02-24 | 2024-02-23 | Novel compounds |
| AU2024224775A AU2024224775A1 (en) | 2023-02-24 | 2024-02-23 | Compounds |
| IL322892A IL322892A (en) | 2023-02-24 | 2024-02-23 | Peptide hormone analogue compounds |
| PCT/GB2024/050504 WO2024175930A1 (en) | 2023-02-24 | 2024-02-23 | Compounds |
| KR1020257031617A KR20250152096A (en) | 2023-02-24 | 2024-02-23 | compound |
| MX2025009969A MX2025009969A (en) | 2023-02-24 | 2025-08-22 | Compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2302686.7A GB202302686D0 (en) | 2023-02-24 | 2023-02-24 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202302686D0 true GB202302686D0 (en) | 2023-04-12 |
Family
ID=85794021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2302686.7A Ceased GB202302686D0 (en) | 2023-02-24 | 2023-02-24 | Novel compounds |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB202302686D0 (en) |
| TW (1) | TW202436329A (en) |
| WO (1) | WO2024175930A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025176999A2 (en) * | 2024-02-23 | 2025-08-28 | Ip2Ipo Innovations Limited | Novel compounds |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| CA1257199A (en) | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| IT1243390B (en) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION. |
| US5907030A (en) | 1995-01-25 | 1999-05-25 | University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
| US5962270A (en) | 1996-02-06 | 1999-10-05 | Bionebraska, Inc. | Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs |
| US6093692A (en) | 1997-09-25 | 2000-07-25 | The University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
| FR2774674B1 (en) | 1998-02-10 | 2000-03-24 | Atochem Elf Sa | PROCESS FOR THE PREPARATION OF AN AQUEOUS SOLUTION OF HYDROGEN PEROXIDE DIRECTLY FROM HYDROGEN AND OXYGEN AND DEVICE FOR IMPLEMENTING SAME |
| US5993414A (en) | 1998-04-23 | 1999-11-30 | Medtronic, Inc. | Implantable device |
| US6436091B1 (en) | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| MX362190B (en) * | 2012-12-21 | 2019-01-08 | Sanofi Sa | Dual glp1/gip or trigonal glp1/gip/glucagon agonists. |
| EP3788063B1 (en) * | 2018-05-04 | 2023-08-09 | Novo Nordisk A/S | Gip derivatives and uses thereof |
| EP3891173A1 (en) * | 2018-12-03 | 2021-10-13 | Antag Therapeutics ApS | Modified gip peptide analogues |
| WO2023139106A2 (en) * | 2022-01-18 | 2023-07-27 | Novo Nordisk A/S | Long-acting gipr antagonists |
-
2023
- 2023-02-24 GB GBGB2302686.7A patent/GB202302686D0/en not_active Ceased
-
2024
- 2024-02-23 WO PCT/GB2024/050504 patent/WO2024175930A1/en not_active Ceased
- 2024-02-23 TW TW113106610A patent/TW202436329A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202436329A (en) | 2024-09-16 |
| WO2024175930A1 (en) | 2024-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202202921D0 (en) | Novel compounds | |
| GB202302686D0 (en) | Novel compounds | |
| GB202300833D0 (en) | Novel compounds | |
| GB202319938D0 (en) | Novel compounds | |
| GB202319820D0 (en) | Novel compounds | |
| GB202318867D0 (en) | Novel compounds | |
| GB202318866D0 (en) | Novel compounds | |
| GB202318175D0 (en) | Novel compounds | |
| GB202317236D0 (en) | Novel compounds | |
| GB202316973D0 (en) | Novel compounds | |
| GB202316972D0 (en) | Novel compounds | |
| GB202316971D0 (en) | Novel compounds | |
| GB202316974D0 (en) | Novel compounds | |
| GB202316975D0 (en) | Novel compounds | |
| GB202315015D0 (en) | Novel compounds | |
| GB202310218D0 (en) | Novel compounds | |
| GB202310221D0 (en) | Novel compounds | |
| GB202308148D0 (en) | Novel compounds | |
| GB202308147D0 (en) | Novel compounds | |
| GB202307972D0 (en) | Novel compounds | |
| GB202307797D0 (en) | Novel compounds | |
| GB202307427D0 (en) | Novel compounds | |
| GB202307426D0 (en) | Novel compounds | |
| GB202305813D0 (en) | Novel compounds | |
| GB202305812D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| COOA | Change in applicant's name or ownership of the application |
Owner name: IP2IPO INNOVATIONS LIMITED Free format text: FORMER OWNER: IMPERIAL COLLEGE INNOVATIONS LIMITED |
|
| AT | Applications terminated before publication under section 16(1) |